Skip to main content
SpringerLink
Log in

Estimation of exposure of man to substances reacting covalently with macromolecules

  • Review
  • Published:
Archives of Toxicology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abbreviations

GC:

Gas chromatography

GC-MS:

gas chromatography-mass spectrometry

HPLC:

high performance liquid chromatography

SFS:

synchronous fluorescence spectrometry

RIA:

radioimmunoassay

ELISA:

enzyme-linked immunosorbent assay

USERIA:

ultrasensitive enzymatic radioimmunoassay

TLC:

thin layer chromatography

ATP:

adenosine 5'-triphosphate

FITC:

fluorescein isothiocyanate

TRITC:

tetramethylrhodamine isothiocyanate

References

  • Adamkiewicz J, Ahrens O, Huh N, Nehls P, Rajewsky MF (1984) High affinity monoclonal antibodies for the specific recognition and quantification of deoxynucleosides structurally modified by N-nitroso compounds. In: N-nitroso compounds: occurrence, biological effects and relevance to human cancer, eds. I. K. O'Neill, R. C. Von Borstel, C. T. Miller, T. Long and H. Bartsch. I. A. R. C. Scientific Publication No. 57, I. A. R. C., Lyon, pp 581–587

    Google Scholar 

  • Adamkiewicz J, Eberle G, Huh N, Nehls P, Rajewsky MF (1985) Quantitation and visualisation of alkyl deoxynucleosides in the DNA of mammalian cells by monoclonal antibodies. Environ Health Perspect 62: 49–55

    PubMed  Google Scholar 

  • Albrecht W, Neumann H-G (1985) Biomonitoring of aniline and nitrobenzene. Hemoglobin binding in rats and analysis of adducts. Arch Toxicol 57: 1–5

    PubMed  Google Scholar 

  • Aldridge WN (1986) The biological basis and measurement of thresholds. Ann Rev Pharmacol Toxicol 26: 39–58

    Google Scholar 

  • Autrup H, Bradley KA, Shamsuddin AKM, Wakhisi J, Wasunna A (1983) Detection of putative adduct with fluorescence characteristics identical to 2,3-dihydro-2(7′-guanyl)-3-hydroxyaflatoxin B1 in human urine collected in Murang'a district, Kenya. Carcinogenesis 4: 1193–1195

    PubMed  Google Scholar 

  • Autrup H, Wakhisi J, Vahakangas K, Wasunna A, Harris CC (1985) Detection of 8,9-dihydro-(7′-guanyl)-9-hydroxyaflatoxin B1 in human urine. Environ Health Perspect 62: 105–108

    PubMed  Google Scholar 

  • Baan RA, Zaalberg OB, Fichtinger-Schepman AMJ, Muysken-Schoen MA, Lansbergen MJ, Lohman PHM (1985) Use of monoclonal and polyclonal antibodies against DNA adducts for the detection of DNA lesions in isolated DNA and in single cells. Environ Health Perspect 62: 81–88

    PubMed  Google Scholar 

  • Bailey E, Farmer PB, Bird I, Lamb JH, Peal JA (1986) Monitoring exposure to acrylamide by the determination of S-(2-carboxyethyl) cysteine in hydrolyzed hemoglobin by gas chromatography-mass spectrometry. Anal Biochem (in press)

  • Bailey E, Farmer PB, Shuker DEG (1986) Urinary 3-methyladenine as a marker of in vivo methylation of DNA. Br J Cancer (in press)

  • Berlin A, Draper M, Hemminki K, Vainio H (eds) (1984) Monitoring human exposure to carcinogenic and mutagenic agents. I. A. R. C. Scientific Publication No. 59, I. A. R. C. Lyon, pp 325–427

    Google Scholar 

  • Bridges BA, Butterworth BE, Weinstein IB (eds) (1982) Indicators of Genotoxic Exposure. Banbury Report 13, Cold Spring Harbor Laboratory, pp 277–558

  • Calleman CJ, Ehrenberg L, Jansson B, Osterman-Golkar S, Segerbäck D, Svensson K, Wachtmeister CA (1978) Monitoring and risk assessment by means of alkyl groups in hemoglobin in persons occupationally exposed to ethylene oxide. J Environ Pathol Toxicol 2: 427–442

    PubMed  Google Scholar 

  • Doll R, Peto R (1981) The causes of cancer: quantitative estimates of available risks of cancer in the United States today. J Natl Cancer Inst 66: 1192–1308

    Google Scholar 

  • Ehrenberg L, Osterman-Golkar S (1980) Alkylation of macromolecules for detecting mutagenic agents. Teratogen Carcinogen Mutagen 1: 105–127

    Google Scholar 

  • Ehrenberg L, Hiesche KD, Osterman-Golkar S, Wennberg I (1974) Evaluation of genetic risks of alkylating agents: tissue doses in the mouse from air contaminated with ethylene oxide. Mutat Res 24: 83–103

    PubMed  Google Scholar 

  • Ehrenberg L, Moustacchi E, Osterman-Golkar S, with an Appendix by Ekman G (1983) Dosimetry of genotoxic agents and dose-response relationships of their effects. Mutat Res 123: 121–182

    PubMed  Google Scholar 

  • Everson RB, Randerath E, Santella RM, Cefalo RC, Avitts TA, Randerath K (1986) Detection of smoking-related covalent DNA adducts in human placenta. Science 231: 54–57

    PubMed  Google Scholar 

  • Farmer PB, Bailey E, Campbell JB (1984) Use of alkylated proteins in the monitoring of exposure to alkylating agents. In: Monitoring human exposure to carcinogenic and mutagenic agents. I. A. R. C. Scientific Publication No. 59, I. A. R. C. Lyon, pp 189–198

    Google Scholar 

  • Farmer PB, Shuker DEG, Bird I (1986a) DNA and protein adducts as indicators of in vivo methylation by nitrosatable drugs. Carcinogenesis 7: 49–52

    PubMed  Google Scholar 

  • Farmer PB, Bailey E, Gorf SM, Törnqvist M, Osterman-Golkar S, Kautiainen A, Lewis-Enright DP (1986b) Monitoring human exposure to ethylene oxide by determination of haemoglobin adducts using gas chromatography-mass spectrometry. Carcinogenesis 7: 637–640

    PubMed  Google Scholar 

  • Forsberg-Karlsson J, Ehrenberg L, Osterman-Golkar S, Hussain S (1983) Estimation of risks of genotoxic effects of benzo(a)pyrene. Tech Rep 80: 27

    Google Scholar 

  • Green LC, Skipper PL, Turesky RJ, Bryant MS, Tannenbaum SR (1984) In vivo dosimetry of 4-aminobiphenyl in rats via a cysteine adduct in hemoglobin. Cancer Res 44: 4254–4259

    PubMed  Google Scholar 

  • Groopman JD, Donahue PR, Zhu J, Chen J, Wogan GN (1985) Aflatoxin metabolism in humans: detection of metabolites and nucleic acid adducts in urine by affinity chromatography. Proc Natl Acad Sci USA 82: 6492–6496

    PubMed  Google Scholar 

  • Gupta RC (1985) Enhanced sensitivity of32P-postlabelling analysis of aromatic carcinogen-DNA adducts. Cancer Res 45: 5656–5662

    PubMed  Google Scholar 

  • Gupta RC, Reddy MV, Randerath K (1982)32-P-Postlabelling analysis of non-radioactive aromatic carcinogen-DNA adducts. Carcinogenesis 3: 1081–1092

    PubMed  Google Scholar 

  • Harris CC, Vahakangas K, Newman MJ, Trivers GE, Shamsuddin A, Sinopoli N, Mann DL, Wright WE (1985) Detection of benzo(a)pyrene diol epoxide-DNA adducts in peripheral blood lymphocytes and antibodies to the adducts in serum from coke oven workers. Proc Natl Acad Sci USA 82: 6672–6676

    PubMed  Google Scholar 

  • Hashimoto K, Aldridge WN (1970) Biochemical studies on acrylamide, a neurotoxic agent. Biochem Pharmacol 19: 2591–2604

    PubMed  Google Scholar 

  • Haugen A, Groopman JD, Hsu IC, Goodrich G-R, Wogan, GN, Harris CC (1981) Monoclonal antibody to aflatoxin B1-modified DNA detected by enzyme immunoassay. Proc. Natl Acad Sci USA 78: 4124–4127

    PubMed  Google Scholar 

  • Higginson J, Muir CS (1979) Environmental carcinogenesis: misconception and limitations to cancer control. J Natl Cancer Inst 63: 1291–1298

    PubMed  Google Scholar 

  • Hoffmann KJ, Streeter AJ, Axworthy DB, Baillie TA (1985) Structural characterization of the major covalent adduct formed in vitro between acetaminophen and bovine serum albumin. Chem Biol Interact 53: 155–172

    PubMed  Google Scholar 

  • Hsu I-C, Poirier MC, Yuspa SH, Grunberger D, Weinstein IB, Yolken RH, Harris CC (1981) Measurement of benzo(a)pyrene-DNA adducts by enzyme immunoassays and radioimmunoassay. Cancer Res 41: 1091–1095

    PubMed  Google Scholar 

  • Jensen RH, Langlois RG, Bigbee WL (1986) Determination of somatic mutations in human erythrocytes by flow cytometry. In: Genetic toxicology of environmental chemicals, part B: Genetic effects and applied mutagenesis, Liss, A. R. Inc. pp 177–184

  • Kautiainen A, Osterman-Golkar S, Ehrenberg L (1986) Misincorporation of alkylated amino acids into hemoglobin — a possible source of background alkylations. Acta Chem Scand B 40: 453–456

    PubMed  Google Scholar 

  • Klasen EA, Rigutti A, Bos A, Bernini LF (1982a) Development of a screening system for the detection of somatic mutations. I. An enzyme immunoassay for the detection of antibodies against specific haemoglobin determinants. J Immunol Methods 54: 241–250

    PubMed  Google Scholar 

  • Klasen EA, Rigutti A, Bos A, Bernini LF (1982b) Development of a screening system for the detection of somatic mutations: detection of monoclonal antibodies specific for haemoglobin determinants. In: Peeters H (ed) Protides of the Biological Fluids, Pergamon Press, Oxford

    Google Scholar 

  • Klasen EA, Rigutti A, Bos A, and Berninn LF (1983) Development of a screening system for the detection of somatic mutations. II. The use of peptides and insoluble protein fragments in a non-competitive solid phase enzyme immunoassay. J Immunol Methods 55: 281–287

    Google Scholar 

  • Lewalter J, Korallus U (1985) Blood protein conjugates and acetylation of aromatic amines. New findings on biological monitoring. Int Arch Occup Environ Health 56: 179–196

    PubMed  Google Scholar 

  • Mohammed GB, Nazareth A, Hayes MJ, Giese RW, Vouros P (1984) GC-MS characteristics of methylated perfluoracyl derivatives of cytosine and 5-methylcytosine. J Chromatogr 314: 211–217

    PubMed  Google Scholar 

  • Murthy MSS, Calleman CJ, Osterman-Golkar S, Segerbäck D, Svensson K (1984) Relationships between ethylation of hemoglobin, ethylation of DNA and administered amount of ethyl methanesulfonate in the mouse. Mutat Res 127: 1–8

    PubMed  Google Scholar 

  • Neumann HG (1980) Dose-response-relationship in the primary lesion of strong electrophilic carcinogens. Arch Toxicol Suppl 3: 69–77

    PubMed  Google Scholar 

  • Neumann HG (1983) Role of extent and persistence of DNA modifications in chemical carcinogenesis by aromatic amines. Recent Results in Cancer Research 84: 77–89

    PubMed  Google Scholar 

  • Neumann HG (1984) Analysis of haemoglobin as a dose monitor for alkylating and arylating agents. Arch Toxicol 56: 1–6

    PubMed  Google Scholar 

  • Nute PE, Papayannopoulou Th, Tatsis B, Stamatoyannopoulos G (1981) Toward a system for detecting somatic-cell mutations. V. Preparation of fluorescent antibodies to hemoglobin Hasharon, a human α chain variant. J Immunol Methods 42: 35–44

    PubMed  Google Scholar 

  • Osterman-Golkar S, Ehrenberg L, Segerbäck D, Hällström I (1976) Evaluation of genetic risks of alkylating agents. II. Haemoglobin as a dose monitor. Mutat Res 34: 1–10

    PubMed  Google Scholar 

  • Osterman-Golkar S, Farmer PB, Segerbäck D, Bailey E, Calleman CJ, Svensson K, Ehrenberg L (1983) Dosimetry of ethylene oxide in the rat by quantitation of alkylated histidine in hemoglobin. Teratogen Carcinogen Mutagen 3: 395–405

    Google Scholar 

  • Osterman-Golkar S, Bailey E, Farmer PB, Gorf SM, Lamb JH (1984) Monitoring exposure to propylene oxide through the determination of hemoglobin alkylation. Scand J Work Environ Health 10: 99–102

    PubMed  Google Scholar 

  • Pereira MA, Chang LW (1981) Binding of chemical carcinogens and mutagens to rat hemoglobin. Chem Biol Interact 33: 301–305

    PubMed  Google Scholar 

  • Perera FP, Poirier MC, Yuspa SM, Nakayama J, Haretzki A, Curmen MM, Knowles DM, Weinstein IB (1982) A pilot project in molecular cancer epidemiology: determination of benzo(a)pyrene-DNA adducts in animal and human tissues by immunoassays. Carcinogenesis 3: 1405–1410

    PubMed  Google Scholar 

  • Phillips DH, Glatt HR, Seidel A, Bochnitschek W, Oesch F, Grover PL (1986) Mutagenic potential of DNA adducts formed by diol-epoxides, triol-epoxides and the K-region epoxide of chrysene in mammalian cells. Carcinogenesis 7: 1739–1743

    PubMed  Google Scholar 

  • Phillips DH, Reddy MV, Randerath K (1984)32P-Postlabelling analysis of DNA adducts formed in the livers of animals treated with safrole, estragole and other naturally occurring alkenyl benzenes. II. Newborn male B6C3F1 mice. Carcinogenesis 5: 1623–1628

    PubMed  Google Scholar 

  • Pilot HC (1986) Fundamentals of oncology, Third Edition. Marcel Dekker, Inc., New York, Basel

    Google Scholar 

  • Ploem JS (1984) Cytometry methods applied to immunocytochemistry. Fresenius Z Anal Chem 317: 650–651

    Google Scholar 

  • Ploem JS (1986) New instrumentation for sensitive image analysis of fluorescence in cells and tissues. In: Lansing Taylor D, Waggoner AS, Lanni F, Murphi RF, Birge R (eds) Fluorescence in the biological sciences. Alan R. Liss Inc., New York (in press)

    Google Scholar 

  • Poirier MC, Lippard SJ, Zwelling LA, Ushay HM, Kerrigan D, Thill CC, Santella RM, Grunberger D, Yuspa DH (1982) Antibodies elicited againstcis-diamminedichloroplatinum (II)-DNA adducts formed in vivo and in vitro. Proc Natl Acad Sci USA 79: 6443–6447

    PubMed  Google Scholar 

  • Poirier MC, Reed E, Zwelling LA, Ozols RF, Litterst CL, Yuspa SH (1985) Polyclonal antibodies to quantitatecis-diamminedichloroplatinum (II)-DNA adducts in cancer patients and animal models. Environ Health Perspect 62: 89–94

    PubMed  Google Scholar 

  • Rahn RO, Change SS, Holland JM, Shugart LR (1982) A fluorimetric-HPLC assay for quantitating the binding of benzo(a)pyrene metabolites to DNA. Biochem Biophys Res Commun 109: 262–268

    PubMed  Google Scholar 

  • Randerath K, Reddy MF, Gupta RC (1981)32P-Labelling test for DNA damage. Proc Natl Acad Sci USA 78: 6126–6239

    PubMed  Google Scholar 

  • Randerath K, Haglund RE, Phillips DH, Reddy MV (1984)32P-Postlabelling analysis of DNA adducts formed in the livers of animals treated with safrole, estragole and other naturally occurring alkenyl benzenes. I. Adult female CD-1 mice. Carcinogenesis 5: 1613–1622

    PubMed  Google Scholar 

  • Randerath K, Randerath E, Agrawal HP, Gupta RC, Schurdak ME, Reddy MV (1985) Postlabelling methods for carcinogen-DNA adduct analysis. Environ Health Perspect 62: 57–65

    PubMed  Google Scholar 

  • Saffhill R, Strickland PT, Boyle JM (1982) Sensitive radioimmunoassay for O6-n-butyl-deoxyguanosine, O2-n-butylthymidine and O4-n-butylthymidine. Carcinogenesis, 3: 547–552

    PubMed  Google Scholar 

  • Santella RM, Lin CD, Dharmaraja N (1986) Monoclonal antibodies to a benzo(a)pyrene diolepoxide modified protein. Carcinogenesis 7: 441–444

    PubMed  Google Scholar 

  • Segerbäck D (1985) In vivo dosimetry of some alkylating agents as a basis for risk estimation. Dissertation of the University of Stockholm

  • Segerbäck D, Calleman CJ, Ehrenberg L, Löfroth G, Osterman-Golkar S (1978) Evaluation of genetic risks of alkylating agents IV. Quantitative determination of alkylated amino acids in haemoglobin as a measure of the dose after treatment of mice with methyl methanesulfonate. Mutat Res 49: 71–82

    PubMed  Google Scholar 

  • Shamsuddin AKM, Sinopoli NT, Hemminki K, Boesch RR, Harris CC (1985) Detection of benzo(a)pyrene: DNA adducts in human white blood cells. Cancer Res 45: 66–68

    PubMed  Google Scholar 

  • Shugart L (1986) Quantifying adductive modification of hemoglobin from mice exposed to benzo(a)pyrene. Anal Biochem 152: 365–369

    PubMed  Google Scholar 

  • Shuker DEG, Bailey E, Gorf SM, Lamb J, Farmer PB (1984) Determination of N-7-[2H3]methyl guanine in rat urine by gas chromatography-mass spectrometry following administration of trideuteromethylating agents or precursors. Anal Biochem 140: 270–275

    PubMed  Google Scholar 

  • Skipper PL, Obiedzinski MW, Tannenbaum SR, Miller DW, Mitchum RK, Kadlubar FF (1985) Identification of the major serum albumin adduct formed by 4-aminobiphenyl in vivo in rats. Cancer Res 45: 5122–5127

    PubMed  Google Scholar 

  • Törnqvist M, Mowrer J, Jensen S, Ehrenberg L (1986a) Monitoring of environmental cancer initiators through hemoglobin adducts by a modified Edman degradation method. Anal Biochem 154: 255–266

    PubMed  Google Scholar 

  • Törnqvist M, Osterman-Golkar S, Kautiainen A, Jensen S, Farmer PB, Ehrenberg L (1986b) Tissue doses of ethylene oxide in cigarette smokers determined from adduct levels in hemoglobin. Carcinogenesis 7: 1519–1521

    PubMed  Google Scholar 

  • Vahakangas K, Trivers G, Rowe M, Harris CC (1985) Benzo(a)pyrene diolepoxide-DNA adducts detected by synchronous fluorescence spectrophotometry. Environ Health Perspect 62: 101–104

    PubMed  Google Scholar 

  • Van Sittert NJ, de Jong G, Clare MG, Davis R, Dean BJ, Wren LJ, Wright AS (1984) Cytogenetic, immunological and haematological effects in workers in an ethylene oxide manufacturing plant. Br J Ind Med 42: 19–26

    Google Scholar 

  • Wild CP, Smart G, Saffhill R, Boyle JH (1983) Radioimmunoassay of O6-methyl-deoxyguanosine in DNA of cells alkylated in vitro and in vivo. Carcinogenesis 4: 1605–1609

    PubMed  Google Scholar 

  • Wild CP, Garner RC, Montesano R, Tursi F (1986) Aflatoxin B1 binding to plasma albumin and liver DNA upon chronic administration to rats. Carcinogenesis 7: 853–858

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. M. R. C. Toxicology Unit, M. R. C. Laboratories, Woodmansterne Road, SM5 4EF, Carshalton, Surrey, UK

    P. B. Farmer

  2. Institut für Pharmakologie und Toxikologie, Universität Würzburg, D-8700, Würzburg, Germany

    H. -G. Neumann & D. Henschler

Authors
  1. P. B. Farmer
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. H. -G. Neumann
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. D. Henschler
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

This report results from a discussion sponsored and organized by the Advisory Subgroup in Toxicology (AST) of the European Science Foundation's Standing Committee for the European Medical Research Councils and held at the Medical Research Council Toxicology Unit, Carshalton, UK. Those taking part were:

W. N. Aldridge (AST); H. Autrup (Fibiger Institute, Copenhagen, Denmark); L. F. Bernini (Department of Human Genetics, Silvius Laboratories, Leiden, The Netherlands); L. Ehrenberg (Department of Radiobiology, University of Stockholm, Sweden); P. Farmer (MRC Toxicology Unit, Carshalton, UK); K. Hemminki (Institute of Occupational Health, Helsinki, Finland); D. Henschler (AST); B. Holmstedt (AST); R. Lauwerys (AST); F. Lembeck (AST); N. Lery (AST); H.-G. Neumann (Institute of Toxicology, University of Würzburg, W Germany); D. H. Phillips (Institute of Cancer Research, Chester Beatty Laboratories, London, UK); J. Purchase (AST); B. Terracini (AST); M. Törnqvist (Department of Radiobiology, University of Stockholm, Sweden); A. S. Wright (Sittingbourne Research Centre, Sittingbourne, UK

Rights and permissions

Reprints and permissions

About this article

Cite this article

Farmer, P.B., Neumann, H.G. & Henschler, D. Estimation of exposure of man to substances reacting covalently with macromolecules. Arch Toxicol 60, 251–260 (1987). https://doi.org/10.1007/BF01234663

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01234663

Keywords

Search

Navigation